Skip to main content

Cannabinoids

  • Chapter

Part of the book series: Modern Analytical Chemistry ((MOAC))

Abstract

The cannabinoids form a group of terpene-related compounds unique to the plant Cannabis sativa L., the source of the drug marijuana. To date, some 70 of these compounds have been identified (1), the major ones having the structures shown in Fig. 6.1. Of these, delta-9-tetrahydrocannabinol (delta-9-THC, I) is the major psychoactive constituent, cannabidiol (CBD, II) is its biosynthetic precursor, and cannabinol (CBN, III) is generally regarded as a chemical degradation product (2). Most of the major cannabinoids possess a pentyl chain, but the complexity of cannabinoid mixtures arises from the presence of lower homologues, of which the propyl series is the best known (3). Methyl (4) and butyl (5) cannabinoids have also been reported, but in low concentration. An interesting feature of the relative abundance of all of the cannabinoids is their dependence on geographical origin and age. Plants grown in temperate regions tend to have low THC contents, whereas those originating in tropical regions contain high concentrations of this cannabinoid. In addition, the relative concentration of the homologues displays a strong regional bias with, for example, propyl cannabinoids being particularly abundant in samples originating from the Indian subcontinent. Further complexity is imparted by the fact that most natural cannabinoids contain a carboxylic acid group either at C-2 (named acid A, IV) or at C-4 (acid B, V). This group is labile, is lost when the drug is smoked, and presents problems when analysis is performed by gas chromatography.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Turner, C. E., ElSohly, M. A., and Boeren, E. G., 1980, Constituents of Cannabis sativa L., XVII: A review of the natural constituents, J. Nat. Prods. 43:169–234.

    Article  CAS  Google Scholar 

  2. Turner, C. E., and ElSohly, M. A., 1979, Constituents of Cannabis sativa L. XVI: A possible decomposition pathway of delta-1-tetrahydrocannabinol to cannabinol, J. Heterocyclic Chem. 16:1667–1668.

    Article  CAS  Google Scholar 

  3. Gill, E. W., 1971, Propyl homologue of tetrahydrocannabinol: Its isolation from cannabis, properties and synthesis, J. Chem. Soc. (C). 1971:579–582.

    Google Scholar 

  4. Vree, T. B., Breimer, D. D., van Ginneken, C. A. M., and van Rossum, J. M., 1972, Identification in hashish of tetrahydrocannabinol, cannabidiol and cannabinol analogues with a methyl side-chain, J. Pharm. Pharmacol. 24:7–12.

    Article  CAS  Google Scholar 

  5. Harvey, D. J., 1976, Characterization of the butyl homologues of delta-1-tetrahydrocannabinol, cannabinol and cannabidiol in samples of Cannabis by combined gas chromatography and mass spectrometry, J. Pharm. Pharmacol. 28:280–285.

    Article  CAS  Google Scholar 

  6. Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., and Bonner, T. L, 1990, Structure of a cannabinoid receptor and functional expression of the cloned cDNA, Nature 346:561–564.

    Article  CAS  Google Scholar 

  7. Harvey, D. J., 1985, Marihuana’ 84; Summary of the session on adverse effects, in: Marihuana’ 84; Proceedings of the Oxford Symposium on Cannabis (D. J. Harvey, ed.), IRL Press, Oxford, pp. 667–670.

    Google Scholar 

  8. Harvey, D. J., and Paton, W. D. M., 1984, Metabolism of the cannabinoids, Rev. Biochem. Toxicol. 6:221–264.

    CAS  Google Scholar 

  9. Harvey, D. J., 1991, Metabolism and pharmacokinetics of the cannabinoids, Biochem. Physiol. Substance Abuse 3:279–365.

    CAS  Google Scholar 

  10. Harvey, D. J., 1985, Mass spectrometry of the cannabinoids and their metabolites, Mass Spectrom. Rev. 6:135–229.

    Article  Google Scholar 

  11. Claussen, U., Fehlaber, H.-W., and Körte, F., 1966, Haschisch—XI. Massenspektrometrische Bestimmung von Haschisch-Inhaltstoffen—III, Tetrahedron 22:3535–3543.

    Article  CAS  Google Scholar 

  12. Harvey, D. J., 1981, The mass spectra of the trimethylsilyl derivatives of delta-1-and delta-6-tetrahydrocannabinol, Biomed. Mass Spectrom. 8:575–578.

    Article  CAS  Google Scholar 

  13. Boeren, E. G., Heerma, W., and Terlouw, J. K., 1976, The use of labeled analogues for the determination of mass spectrometric fragmentation mechanisms of cannabinoids. A reinvestigation of the formation of the most abundant fragment ion [C15H19O2] in delta-1(8)-tetrahydrocan-nabinol, Org. Mass Spectrom. 11:659–663.

    Article  CAS  Google Scholar 

  14. Budzikiewicz, H., Aplin, R. T., Lightner, D. A., Djerassi, C., Mechoulam, R., and Gaoni, Y., 1965, Massenspektroskopie und ihre Anwendung auf strukturelle und stereochemische Probleme. LXVIII. Massenspektroskopische Untersuchung der Inhaltstoffe von Hashische, Tetrahedron 11:1881–1888.

    Article  Google Scholar 

  15. Harvey, D. J., and Brown, N. K., 1992, Identification of cannabichromene metabolites by mass spectrometry: Identification of eight new dihydroxy metabolite? in the rabbit, Biomed. Environ. Mass Spectrom. 20:275–285.

    Article  Google Scholar 

  16. Harvey, D. J., and Brown, N. K., 1990, In vitro metabolism of cannabigerol in several mammalian species, Biomed. Environ. Mass Spectrom. 19:545–553.

    Article  CAS  Google Scholar 

  17. Harvey, D. J., 1981, The mass spectra of the trimethylsilyl derivatives of cis- and trans-hexahydrocannabinol and their hydroxy and acid analogues, Biomed. Mass Spectrom. 8:366–372.

    Article  CAS  Google Scholar 

  18. Turner, C. E., Hadley, K. W., Henry, J., and Mole, W. L., 1974, Constituents of Cannabis sativa, L., VII. Use of silyl derivatives in routine analysis, J. Pharm. Sci. 63:1872–1876.

    Article  CAS  Google Scholar 

  19. Harvey, D. J., and Paton, W. D. M., 1975, Use of trimethylsilyl and other homologous trialkylsilyl derivatives for the separation and characterisation of mono-and di-hydroxycan-nabinoids by combined gas chromatography and mass spectrometry, J. Chromatogr. 109:73–80.

    Article  CAS  Google Scholar 

  20. Harvey, D. J., 1977, Mass spectrometry of the triethylsilyl, tri-n-propylsilyl and tri-n-butylsilyl derivatives of some alcohols, steroids and cannabinoids, Org. Mass Spectrom. 12:473–474.

    Article  CAS  Google Scholar 

  21. Harvey, D. J., 1977, Cyclic alkane boronates as derivatives for the characterisation of cannabinolic acids by combined gas chromatography and mass spectrometry, Biomed. Mass Spectrom. 4:88–93.

    Article  CAS  Google Scholar 

  22. Vree, T. B., Breimer, D. D., van Ginneken, C. A. M., van Rossum, J. M., DeZeeuw, R. A., and Witte, A. H., 1971, Identification of cannabinoids in hashish by a new method of combined GC/MS, Clin. Chim. Acta 34:365–372.

    Article  CAS  Google Scholar 

  23. Vree, T. B., Breimer, D. D., van Ginneken, C. A. M., and van Rossum, J. M., 1972, Identification of cannabicyclol with a propyl or pentyl side-chain by means of combined gas chromatography mass spectrometry, J. Chromatogr. 74:124–127.

    Article  CAS  Google Scholar 

  24. DeZeeuw, R. A., Vree, T. B., Breimer, D. D., and van Ginneken, C. A. M., 1973, Cannabivarichromene, a new canriabinoid with a propyl side chain in cannabis, Experientia 29:260–261.

    Article  CAS  Google Scholar 

  25. Nilsson, I. M., Agurell, S., Nilsson, J. L. G., Ohlsson, A., Sandberg, F., and Wahlqvist, M., 1970, Delta-1-tetrahydrocannabinol: Structure of a major metabolite, Science 168:1228–1229.

    Article  CAS  Google Scholar 

  26. Nordqvist, M., Lindgren, J.-E., and Agurell, S., 1979, Acidic metabolites of delta-1-tetrahydrocannabinol isolated from rabbit urine, J. Pharm. Pharmacol. 31:231–237.

    Article  CAS  Google Scholar 

  27. Harvey, D. J., Martin, B. R., and Paton, W. D. M., 1977, Identification of di-and tri-substituted hydroxy and ketone metabolites of delta-1-tetrahydrocannabinol in mouse liver, J. Pharm. Pharmacol. 29:482–486.

    Article  CAS  Google Scholar 

  28. Harvey, D. J., Martin, B. R., and Paton, W. D. M., 1978, Comparative in vivo metabolism of delta-1-tetrahydrocannabinol (delta-1-THC), cannabidiol (CBD) and cannabinol (CBN) in several species, in: Recent Developments in Mass Spectrometry in Biochemistry and Medicine, Vol. 1 (A. Frigerio, ed.), Plenum Press, New York, pp. 161–184.

    Chapter  Google Scholar 

  29. Harvey, D. J., and Paton, W. D. M., 1979, The metabolism of deuterium-labeled analogues of delta-1-, delta-6-and delta-7-tetrahydrocannabinol and the use of deuterium labelling, in: Recent Developments in Mass Spectrometry in Biochemistry and Medicine, Vol. 2 (A. Frigerio, ed.), Plenum Press, New York, pp. 127–147.

    Chapter  Google Scholar 

  30. Harvey, D. J., and Paton, W. D. M., 1980, The use of deuterium labeling in structural and quantitative studies of tetrahydrocannabinol metabolites by mass spectrometry, Adv. Mass Spectrom. 8:1194–1203.

    Google Scholar 

  31. Harvey, D. J., 1980, Stereospecific elimination of deuterium as a method for determining the stereochemistry of a number of metabolites of the tetrahydrocannabinols, Biomed. Mass Spectrom. 7:28–34.

    Article  CAS  Google Scholar 

  32. Harvey, D. J., and Paton, W. D. M., 1976, Examination of the metabolites of delta-1-tetrahydrocannabinol in mouse liver, heart and lung by combined gas chromatography and mass spectrometry, in: Marihuana: Chemistry, Biochemistry and Cellular Effects (G. G. Nahas, ed.), Springer-Verlag, New York, pp. 93–109.

    Google Scholar 

  33. Harvey, D. J., 1985, Combined gas chromatography-mass spectrometry in metabolic and phar-macokinetic studies of delta-9-tetrahydrocannabinol, in: Pharmacokinetics and Pharmacodynamics of Psychoactive Drugs (G. Barnett and C. N. Chiang, eds.), Biomedical Publications, Foster City, CA, pp. 456–486.

    Google Scholar 

  34. Harvey, D. J., 1981, The mass spectra of the trimethylsilyl derivatives of the hydroxy and acid metabolites of delta-1-and delta-6-tetrahydrocannabinol, Biomed. Mass Spectrom. 8:579–588.

    Article  CAS  Google Scholar 

  35. Wall, M. E., and Brine, D. R., 1976, Identification of cannabinoids and metabolites in biological materials by combined gas-liquid chromatography-mass spectrometry, in: Marihuana: Chemistry, Biochemistry and Cellular Effects (G. G. Nahas, ed.), Springer-Verlag, New York, pp. 51–62.

    Google Scholar 

  36. Binder, M., Agurell, S., Leander, K., and Lindgren, J.-E., 1974, Zur Identifikation potentieller Metabolite von Cannabis-inhaltstoffen: Kernresonanz und massenspektroskopische Untersuchungen und Seitenkettenhydroxylierten Cannabinoiden, Helv. Chim. Acta 57:1626–1641.

    Article  CAS  Google Scholar 

  37. Harvey, D. J., and Paton, W. D. M., 1978, Identification of six substituted 4″-hydroxy-metabolites of delta-1-tetrahydrocannabinol in mouse liver, Res. Commun. Chem. Pathol. Pharmacol. 21:435–446.

    CAS  Google Scholar 

  38. Lyle, M. A., Pallante, S., Head, K., and Fenselau, C., 1977, Synthesis and characterization of glucuronides of cannabinol, cannabidiol, delta-9-tetrahydrocannabinol and delta-8-tetrahydrocannabinol, Biomed. Mass Spectrom. 4:190–196.

    Article  CAS  Google Scholar 

  39. Pallante, S., Lyle, M. A., and Fenselau, C., 1978, Synthesis and characterization of glucuronides of 5′-hydroxy-delta-9-tetrahydrocannabinol and 11-hydroxy-delta-9-tetrahydrocannabinol, Drug Metab. Dispos. 6:389–395.

    CAS  Google Scholar 

  40. Leighty, E. G., Fentiman, A. F., and Foltz, R. L., 1976, Long-retained metabolites of delta-9-and delta-8-tetrahydrocannabinol identified as novel fatty acid conjugates, Res. Commun. Chem. Pathol. Pharmacol. 14:13–28.

    CAS  Google Scholar 

  41. Harvey, D. J., and Brown, N. K., 1990, A method, based on catalytic hydrogénation, for the identification of monohydroxy metabolites of isomeric tetrahydrocannabinols, Rapid Commun. Mass Spectrom. 4:67–68.

    Article  CAS  Google Scholar 

  42. Harvey, D. J., and Brown, N. K., 1991, Electron-impact induced fragmentation of the trimethylsilyl derivatives of monohydroxy-hexahydrocannabinols, Biol. Mass Spectrom. 20:292–302.

    Article  CAS  Google Scholar 

  43. Harvey, D. J., Martin, B. R., and Paton, W. D. M., 1980, Identification of in vivo, liver metabolites of delta-1-tetrahydrocannabinol, cannabidiol and cannabinol produced by the guinea-pig, J. Pharm. Pharmacol. 32:261–271.

    Article  Google Scholar 

  44. Martin, B., Nordqvist, M., Agurell, S., Lindgren, J.-E., Leander, K., and Binder, M., 1976, Identification of monohydroxylated metabolites of cannabidiol formed by a rat liver, J. Pharm. Pharmacol. 28:275–279.

    Article  CAS  Google Scholar 

  45. Martin, B., Agurell, S., Nordqvist, M., and Lindgren, J.-E., 1976, Dioxygenated metabolites of cannabidiol formed by rat liver, J. Pharm. Pharmacol. 28:603–608.

    Article  CAS  Google Scholar 

  46. Martin, B. R., Harvey, D. J., and Paton, W. D. M., 1977, Biotransformation of cannabidiol in mice: Identification of new acid metabolites, Drug Metab. Dispos. 5:259–267.

    CAS  Google Scholar 

  47. Harvey, D. J., Samara, E., and Mechoulam, R., 1991, Urinary metabolites of cannabidiol in dog, rat and man and their identification by GC/MS, J. Chromatogr. 562:299–322.

    CAS  Google Scholar 

  48. Harvey, D. J., and Brown, N. K., 1990, In vitro metabolism of cannabidiol in the rabbit: Identification of seventeen new metabolites including thirteen dihydroxylated in the isopropenyl chain, Biomed. Environ. Mass Spectrom. 19:550–567.

    Google Scholar 

  49. Harvey, D. J., and Brown, N. K., 1990, In vitro metabolism of cannabidiol in seven common laboratory mammals, Res. Commun. Substance Abuse 11:27–37.

    CAS  Google Scholar 

  50. Harvey, D. J., and Mechoulam, R., 1990, Metabolites of cannabidiol identified in human urine, Xenobiotica 20:303–320.

    Article  CAS  Google Scholar 

  51. Samara, E., Bialer, M., and Harvey, D. J., 1990, Identification of urinary metabolites of cannabidiol in the dog, Drug Metab. Dispos. 18:571–579.

    CAS  Google Scholar 

  52. Samara, E., Bialer, M., and Harvey, D. J., 1990, Identification of glucose conjugates as the major urinary metabolites of cannabidiol in the dog, Xenobiotica 20:303–320.

    Article  Google Scholar 

  53. Samara, E., Bialer, M., and Harvey, D. J., 1992, Metabolism of cannabidiol by the rat, Eur. J. Drug Metab. Pharmacokin. 16:305–313.

    Article  Google Scholar 

  54. Widman, M., Nilsson, I. M., Nilsson, J. L. G., Agurell, S., and Leander, K., 1971, Metabolism of cannabis, IX, Cannabinol: Structure of a major metabolite formed in rat liver, Life Sci. 10:157–162.

    Article  CAS  Google Scholar 

  55. Widman, M., Dahmen, J., Leander, K., and Petersson, K., 1975, In vitro metabolism of cannabinol in rat and rabbit liver, synthesis of 2″-, 3″-and 4″-hydroxycannabinol, Acta Pharm. Suec. 12:385–392.

    CAS  Google Scholar 

  56. Harvey, D. J., Martin, B. R., and Paton, W. D. M., 1977, In vivo metabolism of cannabinol by mouse and rat and a comparison with the metabolism of delta-1-tetrahydrocannabinol and cannabidiol, Biomed. Mass Spectrom. 4:364–370.

    Article  CAS  Google Scholar 

  57. Harvey, D. J., and Brown, N. K., 1990, A method for structural determination of cannabichromene metabolites by mass spectrometry, Rapid Commun. Mass Spectrom. 4:135–136.

    Article  CAS  Google Scholar 

  58. Agurell, S., Gustafsson, B., Holmstead, B., Leander, K., Lindgren, J.-E., Nilsson, I., Sandberg, F., and Asberg, M., 1973, Quantitation of delta-1-tetrahydrocannabinol in plasma from cannabis smokers, J. Pharm. Pharmacol. 25:554–558.

    Article  CAS  Google Scholar 

  59. Agurell, S., Levander, S., Binder, M., Bader-Bartfai, A., Gustafsson, B., Leander, K., Lindgren, J. E., Ohlsson, A., and Tobisson, B., 1974, Pharmacokinetics of delta-1-tetrahydrocannabinol in man after smoking: Relations to physiological and psychological effects, Pharmacology of Marijuana (M. C. Braude and S. Szara, eds.), Raven Press, New York, pp. 49–61.

    Google Scholar 

  60. Ohlsson, A., Agurell, S., Lindgren, J.-E., and Leander, K., 1979, Improvement in the mass fragmentographic technique for quantification of tetrahydrocannabinol in human blood plasma, in: Cannabinoid Analysis in Physiological Fluids, ACS Symposium Series, No. 98 (J. A. Vinson, ed.), American Chemical Society, Washington, pp. 73–79.

    Chapter  Google Scholar 

  61. Harvey, D. J., Martin, B. R., and Paton, W. D. M., 1979, Identification and measurement of cannabinoids and their in vivo metabolites by gas chromatography and mass spectrometry, in: Advances in Biosciences, Vols. 22-23, Marihuana, Biological Effects (G. G. Nahas and W. D. M. Paton, eds.), Pergamon Press, Oxford, pp. 45–62.

    Google Scholar 

  62. Ohlsson, A., Lindgren, J.-E., Wahlen, A., Agurell, S., Hollister, L. E., and Gillespie, H. K., 1982, Single-dose kinetics of deuterium-labelled delta-1-tetrahydrocannabinol in heavy and light cannabis users, Biomed. Mass Spectrom. 9:6–10.

    Article  CAS  Google Scholar 

  63. Ohlsson, A., Lindgren, J.-E., Andersson, S., Agurell, S., Gillespie, H., and Hollister, L. E., 1984, Single dose kinetics of cannabidiol in man, in: The Cannabinoids, Chemical, Pharmacologic and Therapeutic Aspects (S. Agurell, W. L. Dewey, and R. E. Willette, eds.), Academic Press, Orlando, pp. 219–225.

    Chapter  Google Scholar 

  64. Ohlsson, A., Johansson, E., Lindgren, J.-E., Agurell, S., Gillespie, H., and Hollister, L. E., 1985, Kinetics of cannabinol in man, in: Marihuana’ 84: Proceedings of the Oxford Symposium on Cannabis (D. J. Harvey, ed.), IRL Press, Oxford, pp. 63–68.

    Google Scholar 

  65. Detrick, R., and Foltz, R. L., 1976, Quantitation of delta-9-tetrahydrocannabinol in body fluids by gas chromatography/chemical ionization mass spectrometry, in: Cannabinoid Assays in Humans (R. E. Willette, ed.), NIDA, Rockville, MD, pp. 88–95.

    Google Scholar 

  66. Foltz, R. L., McGinnis, K. M., and Chin, D. M., 1983, Quantitative measurement of delta-9-tetrahydrocannabinol and two major metabolites in physiological specimens using capillary column gas chromatography and negative chemical ionization mass spectrometry, Biomed. Mass Spectrom. 10:316–323.

    Article  CAS  Google Scholar 

  67. Hunt, D. F., and Crow, F. W., 1978, Electron capture negative ion chemical ionization mass spectrometry, Anal. Chem. 50:1781–1784.

    Article  CAS  Google Scholar 

  68. Harvey, D. J., Leuschner, J. T. A., and Paton, W. D. M., 1980, Measurement of delta-1-tetrahydrocannabinol in plasma to the low picogram range by gas chromatography-mass spectrometry using metastable ion detection, J. Chromatogr. 202:83–92.

    Article  CAS  Google Scholar 

  69. Davis, N. W., 1989, Updating instrument control modes on a VG 7070F, Adv. Mass Spectrom. 11:178–179.

    Google Scholar 

  70. Leuschner, J. T. A., Harvey, D. J., Bullingham, R. E. S., and Paton, W. D. M., Pharmacokinetics of delta-9-tetrahydrocannabinol in rabbits following single or multiple intravenous doses, Drug Metab. Dispos. 14:230–238.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer Science+Business Media New York

About this chapter

Cite this chapter

Harvey, D.J. (1992). Cannabinoids. In: Desiderio, D.M. (eds) Mass Spectrometry. Modern Analytical Chemistry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1173-5_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-1173-5_6

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-1175-9

  • Online ISBN: 978-1-4899-1173-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics